Consumer Health Digest #14-14

Your Weekly Update of News and Reviews
April 20, 2014

Consumer Health Digest is a free weekly e-mail newsletter edited by Stephen Barrett, M.D., with help from William M. London, Ed.D., M.P.H. It summarizes scientific reports; legislative developments; enforcement actions; news reports; Web site evaluations; recommended and nonrecommended books; and other information relevant to consumer protection and consumer decision-making.

Herbalife hit by class-action suit. A class-action lawsuit has been filed by Abdul Awad, an Herbalife shareholder who claims to have bought the company's stock at inflated prices because of false or misleading statements made by the company. Awad is seeking to represent all investors who bought the stock between May 4, 2010 and April 11, 2014. His complaint states:

Toxic supplement product triggers call for greater regulation. Nearly 100 cases of hepatitis (liver inflammation) and liver failure have been linked to the use of OxyElite Pro, a dietary supplement intended for muscle-building or weight loss. In response, Pieter A. Cohen, M.D., has pointed out:

[Cohen P. Hazards of hindsight: Monitoring the safety of nutritional supplements. New England Journal of Medicine 370:1277-1280, 2014]

NSW nurse facing practice ban for administering "alternative" treatments. The New South Wales Civil and Administrative Tribunal has concluded that the registration of nurse-midwife Nola Fraser should be suspended or canceled. The ruling came in response to a complaint by the Health Care Complaints Commission, which alleged that Fraser was involved with an unregistered former medical practitioner (Chittoor Krishnan) in providing insulin potentiation therapy (IPT) and intravenous vitamin therapy to four patients, one of whom was her brother. On April 4, the Tribunal found Fraser guilty of professional misconduct because she had:

Previous Issue|| Next Issue

This page was posted on April 20, 2014.